Michael N. Potter

发表

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, C. Craddock, M. Labopin, 2022 .

Polymerase chain reaction (PCR)‐ and reverse transcription PCR‐based minimal residual disease detection in long‐term follow‐up of childhood acute lymphoblastic leukaemia

L. Foroni, A. Hoffbrand, P. Gameiro, 2002, British journal of haematology.

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.

R. Greil, H. Döhner, M. Minden, 2015, Blood.

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value

L. Foroni, H. Prentice, A. Hoffbrand, 2000, British journal of haematology.

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.

J. Esteve, C. Craddock, M. Labopin, 2022 .

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, M. Labopin, I. Yakoub-Agha, 2022 .

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

A. Børresen-Dale, J. Esteve, C. Desmedt, 2017 .

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

J. Esteve, N. Kröger, C. Craddock, 2015, Haematologica.